Identification of two arginine residues involved in the binding of substrate to neutral endopeptidase 24-11
Le Moual, H.; Beaumont, A.; Roques, B.P.; Crine, P.; Boileau, G.
Matrix . Supplement 1: 99
1992
ISSN/ISBN: 0940-1199 PMID: 1480105 Document Number: 395410
Document emailed within 1 workday
Related Documents
Suckow, M.; von Wilcken-Bergmann, B.; Müller-Hill, B. 1993: Identification of three residues in the basic regions of the bZIP proteins GCN4, C/EBP and TAF-1 that are involved in specific DNA binding EMBO Journal 12(3): 1193-1200Campbell, D.J.; Anastasopoulos, F.; Duncan, A.M.; James, G.M.; Kladis, A.; Briscoe, T.A. 1998: Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats Journal of Pharmacology and Experimental Therapeutics 287(2): 567-577
Wall, K.A.; Hu, J.Y.; Currier, P.; Southwood, S.; Sette, A.; Infante, A.J. 1994: A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism Journal of Immunology 152(9): 4526-4536
Shimamoto, K.; Ura, N.; Iimura, O. 1994: The natriuretic mechanisms of neutral endopeptidase inhibitor in rats Brazilian Journal of Medical and Biological Research 27(8): 1965-1973
Djokić, T.D. 1992: The role of enkephalinase (neutral endopeptidase) in neurogenic inflammation of the respiratory tract Glas. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 42: 107-121
Tamburini, P.P.; Koehn, J.A.; Gilligan, J.P.; Charles, D.; Palmesino, R.A.; Sharif, R.; McMartin, C.; Erion, M.D.; Miller, M.J. 1989: Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide Journal of Pharmacology and Experimental Therapeutics 251(3): 956-961
Skryzdło-Radomańska, B.; Pollard, H.; Schabowski, J.; Radwan, P.; Celiński, K.; Pokora, J.; Gespach, C. 1994: Activity of enkephalinase (EC.3.4.24.11). Neutral endopeptidase (NEP)in human digestive tract epithelial cells Wiadomosci Lekarskie 47(1-2): 13-17
Trapani, A.J.; De Lombaert, S.; Erion, M.D.; Ghai, R.D.; Peppard, J.V.; Lappe, R.W.; Worcel, M. 1993: The pharmacology of CGS 25462: a potent, orally bioavailable, long-acting inhibitor of neutral endopeptidase 24.11 Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 11(5): S220-S221
Bartuś, J.B.; Chłopicki, S. 2003: Effect of neutral endopeptidase inhibition on vascular response induced by exogenous angiotensin i in the isolated rat lung Polish Journal of Pharmacology 55(6): 1071-1078
Richard, V.; Lecomte, J.M.; Thuillez, C. 1993: Systemic and regional hemodynamic effects of a new angiotensin converting enzyme and neutral endopeptidase mixed inhibitor, alatriopril, in the dog Archives des Maladies du Coeur et des Vaisseaux 86(8): 1275-1279
Wickramarachchi, T.; Devi, Y.S.; Mohmmed, A.; Chauhan, V.S. 2008: Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion Plos One 3(3): e1732
Trapani, A.J.; De Lombaert, S.; Kuzmich, S.; Jeng, A.Y. 1995: Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11 Journal of Cardiovascular Pharmacology 26(Suppl): S69-S71
Sharkovska, Y.; Kalk, P.; Karoline von Websky; Relle, K.; Pfab, T.; Alter, M.; Fischer, Y.; Hocher, B. 2011: Renoprotective Effects of Combined Endothelin-Converting Enzyme/Neutral Endopeptidase Inhibitor SLV338 in Acute and Chronic Experimental Renal Damage Clinical Laboratory 57(7-8): 507-515
Wang, C.D.; Buck, M.A.; Fraser, C.M. 1991: Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists Molecular Pharmacology 40(2): 168-179
Maher, D.W.; Strawn, L.M.; Donoghue, D.J. 1993: Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation Oncogene 8(3): 533-541
Benecke, R.; Brotka, J.; Wijsbeek, J.; Franke, J.P.; Bruins, A.P.; de Zeeuw, R.A. 1986: Plant drugs with residues of organochlorine compounds. 2. Identification of residues of DDT and its analogs by comparison of gas chromatography on packed and capillary columns and GC/MS coupling Die Pharmazie 41(7): 499-501
Yaksh, T.L.; Sabbe, M.B.; Lucas, D.; Mjanger, E.; Chipkin, R.E. 1991: Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates Journal of Pharmacology and Experimental Therapeutics 256(3): 1033-1041
Stio, M.; Giachetti, E.; Vanni, P.; Pinzauti, G. 1987: Substrate specificity and kinetic properties of neutral maltase of human granulocytes Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 181(5): 553-559
O'Keefe, P.W.; Meselson, M.S.; Baughman, R.W. 1978: Neutral cleanup procedure for 2,3,7,8-tetrachlorodibenzo-p-dioxin residues in bovine fat and milk Journal - Association of Official Analytical Chemists 61(3): 621-626
Severin, S.E.; Belousova, L.V.; Moskvitina, E.L. 1983: Essential arginine residues of creatine kinase from beef heart mitochondria Biochemistry International 6(2): 149-156